Atherosclerosis
Products Related to Atherosclerosis(88)
- GC494437α-hydroxy CholesterolCAS: 566-26-7Purity: >98.00%
7α-hydroxy Cholesterol is an endogenous oxidized cholesterol metabolite.
- GC49486Meglutol-d3CAS: 59060-36-5Purity: >99.00%
An internal standard for the quantification of meglutol
- GC49496Homocitrulline-d3Purity: >99.00%
An internal standard for the quantification of homocitrulline
- GC49690(3R,5R)-Rosuvastatin (calcium salt)CAS: 1422515-55-6Purity: >95.00%
A potential impurity found in bulk preparations of rosuvastatin
- GC52193EptifibatideCAS: 188627-80-7Purity: >98.00%
Eptifibatide is a cyclic heptapeptide, acts as a competitive antagonist for the activated platelet glycoprotein IIb/IIIa receptor, with anti-platelet activity.
- GC52281Losartan AzideCAS: 727718-93-6Purity: >95.00%
A potential impurity in commercial preparations of losartan
- GC91042Tauro-Obeticholic Acid (sodium salt)CAS: 2278141-79-8Purity: >98.00%
An active metabolite of obeticholic acid
- GC92113FNIII14 (sodium salt)Purity: >95.00%
FNIII14 is an inhibitor of cell adhesion and a peptide derived from the 14th type III repeat, which is part of heparin-binding domain 2, of human, mouse, and rat fibronectin.
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC49443 | 7α-hydroxy Cholesterol | 566-26-7 | >98.00% | |
7α-hydroxy Cholesterol is an endogenous oxidized cholesterol metabolite. | ||||
| GC49486 | Meglutol-d3 | 59060-36-5 | >99.00% | |
An internal standard for the quantification of meglutol | ||||
| GC49496 | Homocitrulline-d3 | - | >99.00% | |
An internal standard for the quantification of homocitrulline | ||||
| GC49629 | 6β-hydroxy Prednisolone | 16355-29-6 | >95.00% | |
A metabolite of prednisolone | ||||
| GC49671 | 2,3-Oxidosqualene | 7200-26-2 | >90.00% | |
An intermediate in the biosynthesis of sterols | ||||
| GC49690 | (3R,5R)-Rosuvastatin (calcium salt) | 1422515-55-6 | >95.00% | |
A potential impurity found in bulk preparations of rosuvastatin | ||||
| GC49784 | AZD 2716 | 1845753-81-2 | >98.00% | |
An sPLA 2 inhibitor | ||||
| GC52193 | Eptifibatide | 188627-80-7 | >98.00% | |
Eptifibatide is a cyclic heptapeptide, acts as a competitive antagonist for the activated platelet glycoprotein IIb/IIIa receptor, with anti-platelet activity. | ||||
| GC52281 | Losartan Azide | 727718-93-6 | >95.00% | |
A potential impurity in commercial preparations of losartan | ||||
| GC52497 | Lactosylceramide (porcine RBC) | - | >98.00% | |
A sphingolipid | ||||
| GC61286 | SP-8356 | 1454885-45-0 | >99.00% | |
| GC90490 | PMX-53 (trifluoroacetate salt) | 514814-99-4 | >95.00% | |
A C5a receptor antagonist | ||||
| GC91042 | Tauro-Obeticholic Acid (sodium salt) | 2278141-79-8 | >98.00% | |
An active metabolite of obeticholic acid | ||||
| GC91136 | XY-4 | 474329-47-0 | >95.00% | |
An agonist of PPARγ | ||||
| GC91933 | E17241 | 1060968-92-4 | >95.00% | |
E17241 is an inducer of the expression of ABCA1, the gene encoding ATP-binding cassette transporter 1; subfamily A (ABCA1). | ||||
| GC92113 | FNIII14 (sodium salt) | - | >95.00% | |
FNIII14 is an inhibitor of cell adhesion and a peptide derived from the 14th type III repeat, which is part of heparin-binding domain 2, of human, mouse, and rat fibronectin. | ||||